OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 05/17/2024
Week ended 05/17/2024
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 05/17/2024
- The Largest Closed M&A Deal of the Week:
- On May 13, 2024, CV Sciences (CVSI: OTCQB), a consumer wellness company specializing in nutraceuticals and based on the company’s hemp extracts and other natural ingredients, closed its $1M purchase of Elevated Softgels. Elevated is a leading manufacturer of encapsulated soft gels and tinctures. CV Science plans to utilize Elevated to produce roughly 50% of its products, producing meaningful cost savings
- The $1M transaction value was paid via $700K of CV Science stock, $100k of cash, and $200K of earnouts.
Week ended 05/17/2024
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.